KMT2A and leukemia: For example, miR-495 functions as a tumor suppressor by targeting essential leukemia-related genes in MLL-rearranged leukemia (Jiang et al., 2012) and by down-regulating cyclin-dependent kinase 6 in glioblastoma multiforme cells (Chen et al., 2013).